Perrigo Consumer Product Growth Slows While Overall Sales Climb

07 Feb 2014

• By Lisa LaMotta

The private labeler reported $53 million in new product sales for its Q2, but says the return to stores of branded OTCs, which had been recalled due to manufacturing problems, continues to diminish its consumer health product sales growth.

Perrigo Co. PLC’s consumer health product sales were flat at $536.3 million for its fiscal 2014 second quarter as $53 million from new product sales were offset by a slow cold and flu season and by branded products returning to stores.

The OTC private label, nutritional product and Rx generic firm on Feb. 6 reported overall sales that beat expectations in...